Catechin-conjugated mesoporous hydroxyapatite nanoparticle: A novel nano-antioxidant with enhanced osteogenic property

• Published in: Colloids and surfaces, B, Biointerfaces Vol. 169; pp. 329 - 339
• Main Authors: Sistanipour, Elnaz, Meshkini, Azadeh, Oveisi, Hamid
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-09-2018
• Subjects: Catechin; Nano-Antioxidant; Osteogenic differentiation; Osteosarcoma; Nano-Antioxidant; Catechin; Osteosarcoma; Osteogenic differentiation
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2018.05.046

Schematic illustration of Cat@MHAP film with enhanced antioxidant and osteogenic properties, as a promising platform for the regeneration of bone defects.
[Display omitted]
•Catechin-conjugated mesoporous hydroxyapatite nanoparticles were synthesized.•Osteoblast-like cells and MSCs selectively adhered on Cat@MHAP film.•Cat@MHAP directed Osteoblast-like cells and MSCs toward osteogenic differentiation.
Hydroxyapatite is the main component of mineral phase of bone which is widely employed for coating metal implants and scaffold materials in synthetic bone grafts owing to its osteoinductive property. In order to improve the bioactivity of hydroxyapatite, mesoporous hydroxyapatite nanoparticles (MHAP) were synthesized and chemically functionalized with 3-aminopropyltriethoxysilane. The amine-functionalized nanoparticles were conjugated with a natural antioxidant, catechin (Cat), through a stable amide linkage. The true structure of the bioconstruct was confirmed by calculating condensed Fukui indices. The functionalized-hydroxyapatite nanoparticles (Cat@MHAP) showed an outstanding antioxidant activity, having reactivity toward hydroxyl and superoxide radicals larger than that of free catechin. To explore the bone cell responses to this material, multilayer nanoparticle films were prepared by MHAP and Cat@MHAP on a glass substrate. Afterward, the short- and long-term responses of cultured mesenchymal stem cells (MSCs), osteosarcoma cells (Saos-2), and doxorubicin-resistant cells (RSaos-2/Dox) on the surface of the prepared films were investigated. Both the MSCs and bone tumor cells selectively adhered onto Cat@MHAP surface as compared with glass and MHAP at initial culture time. Moreover, it was found that Cat@MHAP decreases the proliferation of Saos-2 and RSaos-2/Dox cells in a time-dependent manner, while it supports the growth of MSCs, indicating the ability of Cat@MHAP to distinguish tumor cells from normal ones. Further, Cat@MHAP promotes the osteogenic differentiation in both the MSCs and tumor cells, accompanied by the attenuation of intracellular ROS. From these results, Cat@MHAP is a novel “nano-antioxidant,” which could be considered as a promising biomaterial in treating bone defects, particularly after surgery in osteosarcoma patients.